My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

Regeneron Pharmaceuticals (NQ:REGN)

803.17 +19.52 (+2.49%)

Streaming Delayed Price Updated: 4:00 PM EST, Feb 13, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Regeneron Pharmaceuticals

< Previous 1 2

...

23 24 25 26 27 28 29 30 31

...

49 50 Next >

Is Regeneron Stock a Buy After a Regulatory Blow? ↗

July 07, 2023

Don't write this company's eulogy too fast.

Via The Motley Fool

Meta Platforms To Rally Around 14%? Here Are 10 Other Analyst Forecasts For Thursday ↗

July 06, 2023

Morgan Stanley cut the price target for ArcBest Corporation (NASDAQ: ARCB) from $136 to $125. Morgan Stanley analyst Ravi Shanker maintained an Overweight rating. ArcBest shares fell 3.3% to close at...

Via Benzinga

Is Regeneron's Stock in Trouble After This FDA Rejection? ↗

July 06, 2023

The company's growth rate has been slowing sharply in recent quarters, and Eylea generates the bulk of its product revenue.

Via The Motley Fool

Biotech Blues: Stay Balanced Through July Earnings Season ↗

July 05, 2023

Life Science stocks lack momentum so be prepared for rebalancing and rotation shifts.

Via Talk Markets

The 3 Best Biotech Stocks to Buy In July ↗

July 05, 2023

With these companies fueling sales and earnings with medical innovations and breakthroughs, they may be the best biotech stocks to pick up.

Via InvestorPlace

Check Out What Whales Are Doing With REGN ↗

July 03, 2023

Via Benzinga

Looking Into Regeneron Pharmaceuticals's Recent Short Interest ↗

July 03, 2023

Via Benzinga

Why Regeneron Pharmaceuticals Stock Dipped This Week ↗

June 29, 2023

A key regulatory setback is weighing on the biotech's stock.

Via The Motley Fool

Check Out What Whales Are Doing With REGN ↗

June 28, 2023

Via Benzinga

Stock Market Rally Roars Back Toward Highs; Carnival, Delta, Micron, Nvidia In Focus: Weekly Review ↗

June 30, 2023

Major indexes rebounded strongly and many stocks flashed buy signals.

Via Investor's Business Daily

What Will Amgen Buy Next? ↗

June 29, 2023

The biotech could pursue these two budget-friendly targets.

Via The Motley Fool

Why Catalent Stock Flopped Today ↗

June 28, 2023

The company takes the fall for a failed drug application.

Via The Motley Fool

Why Regeneron Stock Is Trading Lower Today ↗

June 28, 2023

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) shares continue to fall Wednesday after news Tuesday that the FDA issued a Complete Response Letter (CRL) for aflibercept 8 mg Biologics License...

Via Benzinga

Amazon.com To Rally Over 16%? Here Are 10 Other Analyst Forecasts For Wednesday ↗

June 28, 2023

Deutsche Bank cut the price target for Walgreens Boots Alliance, Inc. (NASDAQ: WBA) from $46 to $34. Deutsche Bank analyst George Hill downgraded the stock from Buy to Hold. Walgreens shares fell 0.2%...

Via Benzinga

Where Regeneron Pharmaceuticals Stands With Analysts ↗

June 27, 2023

Via Benzinga

$100 Invested In This Stock 5 Years Ago Would Be Worth $200 Today ↗

June 22, 2023

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For June 28, 2023 ↗

June 28, 2023

Via Benzinga

Why Regeneron Stock Is Falling Today ↗

June 27, 2023

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) shares fell after the FDA issued a Complete Response Letter (CRL) for aflibercept 8 mg Biologics License application due to an ongoing review of...

Via Benzinga

18 Analysts Have This to Say About Regeneron Pharmaceuticals ↗

June 09, 2023

Via Benzinga

Here's How Much You Would Have Made Owning Regeneron Pharmaceuticals Stock In The Last 10 Years ↗

June 07, 2023

Via Benzinga

Regeneron Pharmaceuticals Unusual Options Activity For June 05 ↗

June 05, 2023

Via Benzinga

Regeneron Stock Crumbles After FDA Rejects Its Next Blockbuster Contender ↗

June 27, 2023

The FDA still needs to review its inspection of a third-party facility, Regeneron said late Tuesday.

Via Investor's Business Daily

Large Cap Biopharma Buffeted By Big Gov, Choppy Days Ahead ↗

June 26, 2023

After a huge run-up in stocks since January investors have come to realize that most of the gains have come from the so-called “Magnificent Seven” tech stocks.

Via Talk Markets

Biotech And Healthcare Stocks Lagging ↗

June 21, 2023

Healthcare is a laggard with XLV down YTD but UNH is still a core position.

Via Talk Markets

2 Biotech Stocks You Can Buy and Hold for the Next Decade ↗

June 21, 2023

Gilead and Regeneron Pharmaceuticals both had triple-digit percentage growth over the past decade.

Via The Motley Fool

How to Retire Rich: Biotech Stocks Edition ↗

June 18, 2023

Thanks to its enormous and practically permanent relevancies, the biotech sector offers a great avenue for retirement planning stocks.

Via InvestorPlace

How Biotech Stocks Are Revolutionizing Healthcare Investment Opportunities ↗

June 17, 2023

The field of biotechnology has become a driving force behind groundbreaking medical advancements, offering investors the opportunity to benefit from these innovations. Here are 10 healthcare innovators...

Via Talk Markets

EyePoint's EYP-1901 Tipped to Transform Wet AMD Market, Analyst Predicts Potential $870M Sales by 2035 ↗

June 14, 2023

JonesResearch has initiated coverage of ophthalmic biopharmaceutical company EyePoint Pharmaceuticals Inc (NASDAQ: EYPT) with a Buy rating and

Via Benzinga

2 Stocks to Buy No Matter What Happens in June and Beyond ↗

June 14, 2023

A lot could go wrong in the next few months, but investors should largely ignore all that noise.

Via The Motley Fool

3 Biotech Stocks to Sell in June Before They Crash and Burn ↗

June 06, 2023

Investors should get out of these biotech stocks to sell now that the Covid-19 pandemic is largely over. These's worse in store for them.

Via InvestorPlace

< Previous 1 2

...

23 24 25 26 27 28 29 30 31

...

49 50 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.